Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer

PURPOSE: To identify the optimal dosing strategy for fluorescence guided surgery in patients with head and neck squamous cell carcinoma, we conducted a dose ranging study evaluating the anti-epidermal growth factor receptor (EGFR) therapeutic antibody, panitumumab, that was fluorescently labeled wit...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mol Imaging Biol
Auteurs principaux: Nishio, Naoki, van den Berg, Nynke S., van Keulen, Stan, Martin, Brock A., Fakurnejad, Shayan, Zhou, Quan, Lu, Guolan, Chirita, Stefania U., Kaplan, Michael J., Divi, Vasu, Colevas, Alexander D., Rosenthal, Eben L.
Format: Artigo
Langue:Inglês
Publié: 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7017887/
https://ncbi.nlm.nih.gov/pubmed/31054001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-019-01358-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires